Meet the Team: Staff Profile
Andrew Bomback, MD | |
| Address: | 161 Fort Washington Ave, Suite 202 New York, NY 10032 |
| Phone: | 212.305.0320 |
| Fax: | 212.342.1814 |
Positions and Appointments
| 2010 – present | Assistant Professor of Clinical Medicine Division of Nephrology, Department of Medicine Columbia University College of Physicians and Surgeons |
| 2009 – present | Attending Physician New York-Presbyterian Hospital |
Education and Training
| 2009 – 2010 | Fellowship in Glomerular Diseases, Columbia University College of Physicians and Surgeons |
| 2006 – 2009 | Fellowship in Nephrology and Hypertension, University of North Carolina Hospitals |
| 2004 – 2008 | Internship and Residency, Internal Medicine, University of North Carolina Hospitals |
| 2009 | MPH, Epidemiology, University of North Carolina Gillings School of Global Public Health |
| 2003 | MD, Columbia University College of Physicians and Surgeons |
| 1998 | BA, Classics, Harvard University |
Certifications and Licensures
Certification, American Board of Internal Medicine, Internal Medicine and Nephrology
Licensure, New York, #251905-1
Licensure, North Carolina, #2007-00749
Professional Experience
| 2009 – 2010 | Instructor of Clinical Medicine Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons |
| 2003 | Medical Writer, Elsevier Science |
| 2003 – 2004 | Assistant Research Scientist New York State Psychiatric Institute, Department of Clinical Therapeutics |
| 2000 – 2003 | Research Fellow Center for the Study of Society and Medicine |
Professional Honors
1st place, Clinical Abstract, New York Society of Nephrology, 2010
Steering Committee and Publications Subcommittee, National Kidney Foundation's Kidney Early Evaluation Program (KEEP), 2009-present
Alpha Omega Alpha Editor's Prize, 2008
Doc A. Thurston III Research Fellowship, 2006-2009
Department of Medicine Chairman's Award, 2006
David A. Ontjes Award, 2005
Alpha Omega Alpha, 2002
Simon Rifkind Research Fellowship, 2000
Phi Beta Kappa, 1997
John Harvard Scholarship, 1994-1997
Professional Organizations and Societies
American Society of Nephrology
National Kidney Foundation
American College of Physicians
Publications
Original, peer-reviewed articles
Kshirsagar AV, Bomback AS, Bang H, Gerber LM, Vupputuri S, Shoham DA, Mazumdar M, Ballantyne CM, Paparello JJ, Klemmer PJ. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999-2004). American Journal of Cardiology 2008; 101:401-406.
Bomback AS, Kshirsagar AV, Amamoo MA, Klemmer PJ. Change in proteinuria after adding aldosterone blockers to angiotensin converting enzyme inhibitors or angiotensin receptor blockers in CKD: a systematic review. American Journal of Kidney Diseases 2008; 51:199-211.
Kshirsagar AV, Bang H, Bomback AS, Vupputuri S, Shoham DA, Kern LM, Klemmer PJ, Mazumdar M, August PA. A simple algorithm to predict incident kidney disease. Archives of Internal Medicine 2008; 168:2466-2473.
Bomback AS, Derebail VK, McGregor JG, Kshirsagar AV, Falk RJ, Nachman PH. Rituximab therapy for membranous nephropathy: a systematic review. Clinical Journal of the American Society of Nephrology 2009; 4:734-744.
Bang H, Mazumdar M, Newman G, Bomback AS, Ballantyne CM, Jaffe AS, August PA, Kshirsagar AV. Screening for Kidney Disease in Vascular Patients:
SCreening for Occult REnal Disease (SCORED) experience. Nephrology Dialysis Transplantation 2009; 24:2452-2457.
Bomback AS, Katz R, He K, Shoham DA, Burke GL, Klemmer PJ. Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multiethnic Study of Atherosclerosis (MESA). American Journal of Clinical Nutrition 2009; 90:1172-1178.
Bang H, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, Callahan MA, Teutsch SM, Mushlin AI, Kern LM. Development and validation of a patient self-assessment score for diabetes risk. Annals of Internal Medicine 2009; 151:775-783.
Bomback AS, Muskala P, Bald E, Chwatko G, Nowicki M. Low dose spironolactone, added to long-term ACE-inhibitor therapy, reduces blood pressure and urinary albumin excretion in obese patients with hypertensive target organ damage. Clinical Nephrology 2009; 72:449-456.
Bomback AS, Kshirsagar AV, Ferris ME, Klemmer PJ. Disordered aldosterone-volume relationship in end stage kidney disease. Journal of the Renin Angiotensin Aldosterone System 2009; 10:230-236.
Harward DH, Bomback AS, Jennette CE, Amamoo MA, Falk RJ. The Kidney Education Outreach Program (KEOP)'s Community-based Screenings: Participants' Demographics and Screening Results. North Carolina Medical Journal 2009, 70:507-512.
Bomback AS, Kshirsagar AV, Whaley-Connell AT, Chen S, Li S, Klemmer PJ, McCullough PA, Bakris GL. Racial Differences in Kidney Function Among Individuals With Obesity and Metabolic Syndrome: Results From the Kidney Early Evaluation Program (KEEP). American Journal of Kidney Diseases 2010; 55:S4-S14.
Stevens LA, Li S, Wang C, Huang C, Becker BN, Bomback AS, Brown WW, Burrows NR, Jurkovitz CT, McFarlane SI, Norris KC, Shlipak M, Whaley-Connell AT, Chen SC, Bakris GL, McCullough PA. Prevalence of CKD and Comorbid Illness in Elderly Patients in the United States: Results From the Kidney Early Evaluation Program (KEEP). American Journal of Kidney Diseases 2010; 55:S23-S33.
Bomback AS, Derebail VD, Shoham DA, Anderson CA, Steffen LM, Rosamond WD, Kshirsagar AV. Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney International 2010; 77:609-616.
Kshirsagar AV, Chiu Y, Bomback AS, August PA, Viera AJ, Colindres RE, Bang H. A Hypertension Risk Score for Middle-Aged and Older Adults. The Journal of Clinical Hypertension 2010; 12:800-808.
Bomback AS, Rekhtman Y, Whaley-Connell AT, Kshirsagar AV, Sowers JR, Chen SC, Li S, Chinnaiyan KM, Bakris GL, McCullough PA. Gestational diabetes alone, in the absence of subsequent diabetes, is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP). Diabetes Care 2010; 33:2586-2591.
Whaley-Connell A, Bomback AS, McFarlane SI, Li S, Roberts T, Chen SC, Collins AJ, Norris KC, Bakris GL, Sowers JR, McCullough PA. Diabetic cardiovascular disease predicts chronic kidney disease awareness in the Kidney Early Evaluation Program. Cardiorenal Medicine 2011; 1:45-52.
Bomback AS, Tumlin JA, Baranski JJ, Bourdeau JE, Besarab A, Radhakrishnan J, Appel GB. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel. Drug Design, Development and Therapy 2011; 5:147-153.
Bomback AS, Appel GB, Radhakrishnan J, Shirazian S, Herlitz L, Stokes MB, D'Agati VD, Markowitz GS. ANCA-associated glomerulonephritis in the very elderly. Kidney International 2011; 79:757-764.
Case reports
Bomback AS, Klemmer PJ. Jack London's "mysterious malady." American Journal of Medicine 2007; 120:466-467.
Bomback AS, Klemmer PJ. Jack London's "chronic interstitial nephritis": a historical differential diagnosis. Pharos 2008; 71:26-30.
Bomback AS, Woosley JT, Kshirsagar AV. Colonic necrosis due to sodium polystyrene sulfate (Kayexalate®). American Journal of Emergency Medicine 2009; 27: 753.e1-2.
Rekhtman Y, Bomback AS, Nash MA, Cohen SD, Matalon A, Jan D, Kaufman H, Axelrod F, Radhakrishnan J, Appel GB. Renal transplantation in familial dysautonomia: Report of two cases and review of the literature. Clinical Journal of the American Society of Nephrology 2010; 5:1676-1680.
Bomback AS, Song H, D'Agati VD, Cohen SD, Neal A, Appel GB, Rovin BH. A new apolipoprotein E mutation, apoE Las Vegas, in a European American with lipoprotein glomerulopathy. Nephrology Dialysis Transplantation 2010; 25:3442-3446.
Reviews, Chapters, and Editorials
Bomback A. The physical exam and the sense of smell. New England Journal of Medicine 2006; 354:327-329.
Bomback A. Errands. Journal of the American Medical Association 2006; 295: 731-733.
Covey LS, Bomback A, Yan GY. History of major depression and smoking cessation: a rejoinder. Nicotine and Tobacco Research 2006; 8: 315-319.
Bomback AS, Bove RM, Klemmer PJ. Of snakes and men: the evolution of ACE inhibitors. Journal of the Renin Angiotensin Aldosterone System 2007; 8:1-2.
Bomback AS, Klemmer PJ. Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: a reply. Nephrology Dialysis Transplantation 2007; 22:1787-1788.
Bomback AS, Klemmer PJ. The incidence and implication of aldosterone breakthrough. Nature Clinical Practice Nephrology 2007; 3:486-492.
Bomback AS. 32 year old man with worsening dyspnea on exertion (aortic valve disease). Liles EA, Wardrop RM (editors). Internal Medicine/Pediatrics Case-Based Review. McGraw-Hill, 2008.
Bomback AS, Klemmer PJ. Renal injury in extreme obesity: the important role of aldosterone. Kidney International 2008; 74:1216.
Klemmer PJ, Bomback AS. Extracellular volume and aldosterone interaction in chronic kidney disease. Blood Purification 2009; 27:92-98.
Bomback AS, Kshirsagar AV, Klemmer PJ. Renal aspirin: will all chronic kidney disease patients someday take spironolactone? Nature Clinical Practice Nephrology 2009; 5:74-75.
Bomback AS, Klemmer PJ. The interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review. American Journal of Nephrology 2009; 30:140-146.
Bomback AS, Klemmer PJ. Obesity-induced kidney injury and the interaction of aldosterone and extracellular volume. European Nephrology 2009, 3:10-12.
Bomback AS, Klemmer PJ. Obesity-induced kidney injury and the interaction of aldosterone and extracellular volume. US Nephrology 2009; 3:16-18.
Bomback AS, Toto RD. Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin II receptor blocker combination. American Journal of Hypertension 2009; 22:1032-1040.
Bomback AS. Some of the people all of the time, all of the people none of the time. American Journal of Kidney Diseases 2009, 54:xxxiii-xxxv.
Bomback AS, Derebail VK, Kshirsagar AV. Response to "Sugar-sweetened soda consumption, hyperuricemia, and kidney disease." Kidney International 2010; 78:708-709.
Bomback AS, Appel GB. Updates on the treatment of lupus nephritis. Journal of the American Society of Nephrology 2010; 21:2028-2035.
Volk M, Bomback AS, Klemmer PJ. Aldosterone receptor antagonists in chronic kidney disease. Current Hypertension Reports, in press.
Books
Bomback A. You're Too Wonderful to Die (fiction). Durham, United Kingdom: Flame Books, 2007.
Bomback AS, Bakris GL. Chronic Kidney Disease and Hypertension Essentials. Boston, Massachusetts: Jones and Bartlett Publishers, 2010.
Abstracts, posters, and presentations
Bomback AS, Covey LS. A re-analysis of Hitsman et al.'s "History of depression and smoking cessation outcome: a meta-analysis." 10th Annual Meeting, Society for Research on Nicotine and Tobacco February 2004.
Bomback AS, Bang H, Vupputuri S, et al. A simple algorithm to predict incident kidney disease. 40th Annual Meeting, American Society of Nephrology November 2007.
Bomback AS, Kshirsagar AV, Amamoo MA, Klemmer PJ. Aldosterone blockade as additive therapy in progressive chronic kidney disease: a systematic review. 40th Annual Meeting, American Society of Nephrology November 2007.
Bomback AS. What is the Role of Aldosterone Blockade in the Approach to RAAS Blockade and Proteinuria? 41st Annual Meeting, American Society of Nephrology November 2008.
Bomback AS, Derebail VK, Shoham DA, Anderson CA, Steffen LM, Rosamond WD, Kshirsagar AV. Regular soda consumption, hyperuricemia, and kidney disease in the Atherosclerosis Risks in Communities Study. 42nd Annual Meeting, American Society of Nephrology November 2009.
Volk M, Bomback AS, Klemmer PJ. Hemodialysis reduces pulse pressure via changes in extracellular volume. 42nd Annual Meeting, American Society of Nephrology November 2009.
Raimann J, Liu L, Sipahioglu M, Usvyat L, Bomback A, Klemmer P, Zhu F, Kotanko P, Levin N. Decrease in extracellular volume results and its possible impacts on anemia management. 42nd Annual Meeting, American Society of Nephrology November 2009.
Bomback AS, Kshirsagar AV, Whaley-Connell AT, Chen S, Li S, Klemmer PJ, McCullough PA, Bakris GL. Racial Differences in Kidney Function Among Individuals With Obesity and Metabolic Syndrome: Results From the Kidney Early Evaluation Program (KEEP). National Kidney Foundation Spring Clinical Meetings April 2010.
Rekhtman Y, Bomback AS, Nash MA, Cohen SD, Matalon A, Jan D, Kaufman H, Axelrod F, Radhakrishnan J, Appel GB. Renal Transplantation in Familial Dysautonomia: Report of two cases and review of the literature. National Kidney Foundation Spring Clinical Meetings April 2010.
Bomback AS, Appel GB, Radhakrishnan J, Shirazian S, Herlitz L, Stokes MB, D'Agati VD, Markowitz GS. ANCA-associated glomerulonephritis in the very elderly. New York Society of Nephrology Spring Meeting May 2010.
Bomback AS, Tumlin JA, Baranski JJ, Bourdeau JE, Besarab A, Radhakrishnan J, Appel GB. The treatment of resistant nephrotic syndrome with Acthar gel (ACTH). 43rd Annual Meeting, American Society of Nephrology November 2010.
Bomback AS, Appel GB, Radhakrishnan J, Shirazian S, Herlitz L, Stokes MB, D'Agati VD, Markowitz GS. ANCA-associated glomerulonephritis in the very elderly. 43rd Annual Meeting, American Society of Nephrology November 2010.
Canetta PA, Huerta A, Bomback AS, Radhakrishnan J, Appel GB. Reduced eGFR in IgA nephropathy predicts poor response to corticosteroid treatment. 43rd Annual Meeting, American Society of Nephrology November 2010.
Huerta A, Liakopoulos V, Palanisamy A, Bomback AS, Radhakrishnan J, Markowitz GS, Appel GB. Renal limited "lupus like" glomerulonephritis. 43rd Annual Meeting, American Society of Nephrology November 2010.
de Lorenzo A, Salanova L, Bomback A, Moya M, Coronel F, Bernis C, Sánchez-Tomero JA, Álvarez V. Antiproteinuric effect of oral paricalcitol combined with renin-angiotensin-aldosterone system blockers in CKD. World Congress of Nephrology April 2011.
Bomback A, Fervenza F, Cattran D, Irazabal V, Eirin A, Radhakrishnan J, Appel GB. Treatment of idiopathic membranous nephropathy with ACTH gel (Acthar). World Congress of Nephrology April 2011.
Huerta A, Bomback A, Canetta P, Radhakrishnan J, Herlitz L, Stokes M, D'Agati V, Markowitz S, Appel G. Clinical and histopathologic prognostic factors in IgA nephropathy. World Congress of Nephrology April 2011.
Babyev R, Whaley-Connell AT, Kshirsagar AV, Navaneethan S, Chen S, Li S, McCullough PA, Bakris GL, Bomback AS. Race does not influence ESRD and mortality in obese patients with CKD stages 3-4: Results From the Kidney Early Evaluation Program (KEEP). National Kidney Foundation Spring Clinical Meetings April 2011.
